Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Hicks Derek
EVP, Chief Business Officer at Intellia Therapeutics. Filing since 4 Jan 2023.
CIK 0001901282
Company
Date
Role
Action
Shares
Amount
Of holding
NTLA
Intellia Therapeutics, Inc.
3 Jan 2025
EVP, Chief Business Officer
Sold at will
6,502
$79.19K
9.8%
NTLA
Intellia Therapeutics, Inc.
3 Jan 2024
EVP, Chief Business Officer
Sold at will
3,877
$114.22K
9.5%
NTLA
Intellia Therapeutics, Inc.
4 Jan 2023
EVP, Chief Business Officer
Sold, plan not stated
1,812
$67.42K
9.5%
3 decisions on file.
